Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CGTXthis companyCognition Therapeutics, Inc.	$0.69	-4.22×	2.87×	0×	-2.67×	-14.9%	0.0%	0.0%	0.0%	-68.5%	-136.9%	-25.0%	0.02×	1.56×	-3,676.85×	3.45×	0.0%	1	-0.97	2	C+
AGENAgenus Inc.	$7.55	-923.53×	-0.34×	0.82×	6.84×	-468.1%	29.6%	-18.0%	0.1%	-0.0%	-34.5%	-170.2%	-1.24×	5.34×	-0.37×	0.41×	0.0%	6	-14.32	2	C+
ATOSAtossa Therapeutics, Inc.	$2.14	-2.19×	1.94×	0×	-1×	88.9%	0.0%	0.0%	0.0%	-88.4%	-94.4%	-39.1%	0×	1.19×	0×	5.53×	0.0%	1	-11.86	2	B-
GLSIGreenwich LifeSciences, Inc.	$16.47	-14.69×	805.09×	0×	-14.37×	-99.2%	0.0%	0.0%	0.0%	-5480.5%	-5505.9%	-3.5%	0×	0.32×	0×	1.06×	0.0%	1	2.27	1	D+
IRDOpus Genetics, Inc.	$4.27	-2.51×	81.49×	88.1×	-25.08×	-106.9%	100.0%	-271.9%	-349.3%	-323.1%	-90.9%	-2.8%	0×	0.94×	-26.33×	6.43×	0.0%	3	-4.73	2	C
MCRBSeres Therapeutics, Inc.	$2.00	23.25×	2.98×	167.07×	17.2×	-266.7%	-423.8%	-11910.1%	721.9%	12.9%	-72.7%	0.7%	1.88×	3.78×	0×	2.56×	0.0%	3	-14.74	1	C-
Peer median	—	-2.51×	2.98×	0.82×	-1×	-106.9%	0.0%	-18.0%	0.0%	-88.4%	-90.9%	-3.5%	0×	1.19×	0×	2.56×	0.0%	3	-11.86	2	—